Integrative clinical and molecular analysis of advanced biliary tract cancers on immune checkpoint blockade reveals potential markers of response
Jingjing Li(Zhejiang Cancer Hospital), Jieer Ying(Chinese Academy of Medical Sciences & Peking Union Medical College), Hanguang Hu(Zhejiang University), Lingnan Zhang(Zhejiang Cancer Hospital), Fufeng Wang, Mengmeng Wu, Yutong Ma, Junrong Yan, Cong Luo(Central South University), Jiachen He, Lei Chen(Zhejiang Cancer Hospital), Da Li(Sir Run Run Shaw Hospital), Wei Wu(Tianjin University), Qi Xu(China Jiliang University), Jianguo Zhao(Shaoxing People's Hospital), Qing Wei(Chinese Academy of Sciences), Xiaoying Wu(Johns Hopkins University), Xiu Zhu(Zhejiang Cancer Hospital), Jun Sima(Hangzhou Red Cross Hospital), Yang Shao(Sanya University), Jinlin Hu(Zhejiang Cancer Hospital), Haibo Mou(Zhejiang Shuren University)
Cited by 24
Related Papers
Hepatogastroenterology
|Hepatogastroenterology|2012|1.3k
Longitudinal pattern of regional brain volume change differentiates normal aging from MCI
|Neurology|2009|536
Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial
|Journal of Clinical Oncology|2021|417